Takahasi K, Sakurada T, Sakurada S, Kuwahara H, Yonezawa A, Ando R, Kisara K
Department of Pharmacology, Tohoku College of Pharmacy, Sendai, Japan.
Neuropharmacology. 1987 Sep;26(9):1289-93. doi: 10.1016/0028-3908(87)90089-x.
Intrathecal injection of substance P produced a behavioural syndrome, consisting of reciproacal hindlimb scratching and biting or fore- and hind-licking. Pretreatment with either an analogue of substance P, (D-Pro2, D-Trp7,9)-substance P (DPDT-SP) or (D-Arg1, D-Pro2,4, D-Trp7,9, Leu11)-substance P, given intrathecally, reduced the response to substance P in a dose-dependent manner. The behaviour induced by substance P was also inhibited by intrathecal, intracerebroventricular (i.c.v.) or intraperitoneal (i.p.) injection of morphine. Intrathecal or subcutaneous injection of naloxone showed a biphasic effect on substance P response; the substance P-induced nociceptive response was increased by a small dose of naloxone, while it was inversely decreased by a large dose of naloxone. The results with analogues of substance P support the hypothesis that substance P, injected intrathecally, acts directly on substance P receptors in the spinal cord. The nociceptive response induced by substance P appears to be controlled by endogenous opioids in the spinal cord.
鞘内注射P物质可产生一种行为综合征,表现为后肢交替抓挠、啃咬或前后肢舔舐。鞘内预先注射P物质类似物,即(D - Pro2,D - Trp7,9)- P物质(DPDT - SP)或(D - Arg1,D - Pro2,4,D - Trp7,9,Leu11)- P物质,可剂量依赖性地降低对P物质的反应。鞘内、脑室内(i.c.v.)或腹腔内(i.p.)注射吗啡也可抑制P物质诱导的行为。鞘内或皮下注射纳洛酮对P物质反应呈现双相效应;小剂量纳洛酮可增强P物质诱导的伤害性反应,而大剂量纳洛酮则使其反向降低。P物质类似物的实验结果支持以下假说:鞘内注射的P物质直接作用于脊髓中的P物质受体。P物质诱导的伤害性反应似乎受脊髓内源性阿片类物质的控制。